Khosrovi Behzad 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Nov 15, 2010
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2009-10-06+30,000→ 324,200 totalExercise: $1.75From: 2010-10-06Exp: 2019-10-06→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on October 7, 2009. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 324,200 not 124,200.